Revenue distribution by industry:

• Telemedicine: 50%
• Prescription drugs: 30%
• Over-the-Counter products: 20%

TOP 3 markets and their percentage shares:

• USA: 70%
• Canada: 15%
• United Kingdom: 10%

Hims & Hers Health, Inc. generates the majority of its revenue from telemedicine, followed by prescription drugs and OTC products. The U.S. market dominates with a 70% share of total revenue, reflecting the company's strong presence and focus on the domestic market. Canada and the United Kingdom are also important markets, accounting for 25% of the revenue together.

Production Sites: USA (As of 2023)

Hims & Hers Health, Inc. is a company specializing in telemedicine and the sale of health and wellness products. The production of the products mainly takes place in the USA, with the company collaborating with various contract manufacturers to develop and produce its products.

This strategy enables Hims & Hers to flexibly respond to market demands while ensuring the quality standards required for their health products.

Revenue Growth: 20% (estimated 2024)
Customer Growth: 25% (estimated 2024)

Hims & Hers Health, Inc. is pursuing a growth strategy that heavily focuses on expanding its digital health platform. The company is investing in expanding its product offerings, particularly in the area of telemedicine services and over-the-counter health products.

Another key focus is on entering new markets and internationalization. Through strategic partnerships and acquisitions, Hims & Hers plans to expand its market presence and reach new customer segments.

Additionally, the company is leveraging technological innovations to enhance user experience and increase customer retention. This includes optimizing the platform through AI-driven health solutions and personalized recommendations.

Hims & Hers Health, Inc. is a company specializing in telemedicine and the sale of health and wellness products. As the company mainly operates in the digital health services sector, physical raw materials or materials are not the primary focus of their business model.

However, some of the products they distribute, such as dietary supplements or over-the-counter medications, may require raw materials. These raw materials could be imported from various countries, depending on the type of product and specific ingredients.

Possible raw materials:

• Pharmaceutical active ingredients
• Packaging materials

Possible countries of origin:

• China and India are leading exporters of pharmaceutical active ingredients.
• Packaging materials could come from various countries, depending on the supplier network.

Since Hims & Hers Health, Inc. does not disclose specific information about their raw material suppliers, this assessment is based on typical industry practices.

Market Share: Estimated 5-7% in the digital health market (2025)

Revenue Growth: 30% (2024)

Customer Satisfaction: High ratings in online reviews and platforms

Hims & Hers Health, Inc. has established itself as a significant player in the digital health market. The company benefits from a diversified product portfolio ranging from over-the-counter medications to telemedicine services.

A key competitive advantage is the strong brand awareness and the ability to target a younger, technology-savvy audience. Furthermore, the company has solidified its market position through strategic partnerships and continuous innovations.

Despite intense competition in the industry, especially from established healthcare providers and new digital start-ups, Hims & Hers remains competitive through its customer-oriented strategy and the use of data analytics to enhance the customer experience.

Institutional Investor Share: 65% (estimated for 2025)

Insider Buys/Sells: No significant changes in the last quarter (2025)

The institutional investor share in Hims & Hers Health, Inc. is estimated to be 65%, indicating a strong confidence from investment funds and other large institutional investors in the company. These investors typically value the company's long-term growth prospects and stability.

There were no significant insider buys or sells in the last quarter, suggesting that the management and other insiders are currently not making significant changes to their holdings. This can be interpreted as a sign of stability and confidence in the current company strategy.

Market share of Hims & Hers Health, Inc.: 5% (estimated, 2025)

Top competitors and their market shares:

1. Teladoc Health, Inc.: 20%
2. CVS Health Corporation: 15%
3. Walgreens Boots Alliance, Inc.: 12%
4. Amazon Pharmacy: 10%
5. GoodRx Holdings, Inc.: 8%
6. Hims & Hers Health, Inc.: 5%
7. Rite Aid Corporation: 4%
8. Ro (Roman Health Ventures): 3%
9. Lemonaid Health: 2%
10. Nurx: 1%

Moat of Hims & Hers Health, Inc.:

Hims & Hers Health, Inc. has built a certain moat through a strong brand identity and direct customer engagement via digital channels. The company offers a user-friendly platform tailored to the needs of the younger generation, setting it apart from more traditional healthcare providers.

However, larger competitors like Teladoc Health and CVS Health have deeper financial resources and a broader range of services, giving them a significant advantage. These companies have established networks and partnerships in the healthcare sector that help them secure and expand market share.

Overall, Hims & Hers Health has a moderate moat supported by its specialized niche and innovative approaches. Nevertheless, they must continuously invest in technology and customer retention to keep pace with the larger, better-funded competitors and defend their market share.

Revenue Growth: 79% (2023) User Growth: 88% (2023)

Hims & Hers Health, Inc. has experienced remarkable revenue growth of 79% in 2023. This indicates strong demand for their telemedicine and health products. Additionally, the company was able to expand its user base by 88% during the same period, signaling successful customer acquisition and retention.

Hims & Hers' growth strategy, focusing on expanding their product offerings and entering new markets, could continue to have positive impacts on business development. Continuous investment in technology and marketing strengthens their position in the digital health sector.

Analysts see potential for further growth in the increasing acceptance of telemedicine and the growing demand for personalized health solutions. The company's ability to scale its services and form new partnerships will be crucial for future success.

Overall, Hims & Hers Health, Inc. could present an attractive investment opportunity, especially for investors who believe in the long-term growth potential of the digital health industry.

Dividend: No payout (2025)

Hims & Hers Health, Inc. currently does not pay a dividend. The company has so far focused on investing its resources in the growth and expansion of its business model.

As a growth-oriented company, it is common for profits to be reinvested to gain market share and develop new products. A dividend payment could be considered in the future once the company has reached a more stable and mature phase.